NASDAQ$SEER
Seer Inc · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Seer's Q4 2021 financial results were reported, demonstrating market progress with $3.1 million in revenue and advancements in commercial release of the Proteograph Product Suite.
Seer, Inc. reported a revenue of $3.1 million for Q4 2021, a significant increase compared to the previous year. The company's net loss for the quarter was $19.7 million. Broad commercial release of the Proteograph Product Suite commenced, with multiple orders pre-booked.
- Revenue reached $3.1 million, driven by increased sales of the Proteograph Product Suite.
- Gross profit for the quarter was $1.4 million, with a gross margin of 47%.
- Operating expenses increased to $21.3 million due to higher employee compensation and costs related to being a publicly traded company.
- Net loss was $19.7 million, compared to $12.9 million in the prior year period.
Headline financials
Revenue & EPS history
Seer · Revenue · Quarterly
$3.07M
Revenue by segment
Seer · $3.03M total across 2 segments · Q4 2021
- Product Revenue$1.88M—62.1%
- Related Party Revenue$1.15M—37.9%
Forward guidance
Seer expects full year 2022 revenue to be in the range of $14.0 million to $16.0 million and plans to increase investments in commercial, operations, and research and development activities.
Tailwinds
- Seer expects full year 2022 revenue to be in the range of $14.0 million to $16.0 million.
- The company plans to increase investments in its commercial activities.
- The company plans to increase investments in its operations activities.
- The company plans to increase investments in its research and development activities.
- Seer aims to drive long-term growth and value creation.
Headwinds
- Increased investments in commercial, operations, and R&D activities may impact profitability in the short term.
- The company's outlook is subject to various risks and uncertainties.
- Actual results may differ materially from the company's expectations.
- The company's ability to achieve its revenue targets depends on market conditions and customer demand.
- Continued investments may lead to increased operating expenses.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2021
-1.1%
Avg return
Earnings day
-3.4%
Avg return
5 days after
-1.3%
Avg return
30 days after
38%
9 / 24 earnings
Positive
+39.4%
Q4 2022
Best reaction
-33.3%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.7% | -7.7% | — | |
| Q4 2025 | -17.4% | -11.1% | -20.2% | |
| Q3 2025 | -1.4% | -4.6% | -13.4% | |
| Q1 2025 | +10.0% | +7.8% | +7.8% | |
| Q4 2024 | -4.5% | -7.3% | -20.9% | |
| Q3 2024 | +9.4% | +10.3% | +22.2% | |
| Q2 2024 | +0.0% | -1.2% | -4.7% | |
| Q1 2024 | -6.8% | -10.0% | -21.7% | |
| Q4 2023 | +1.1% | +6.1% | +5.6% | |
| Q3 2023 | -7.4% | -11.4% | -5.1% | |
| Q2 2023 | -33.3% | -40.6% | -43.6% | |
| Q1 2023 | -2.2% | -11.2% | +33.7% | |
| Q4 2022 | +39.4% | +20.8% | -1.3% | |
| Q3 2022 | -3.4% | +22.0% | -7.4% | |
| Q2 2022 | +19.5% | +6.9% | -12.4% | |
| Q1 2022 | +5.5% | -5.7% | +5.7% | |
| Q4 2021 | -6.6% | -15.3% | +1.8% | |
| Q3 2020 | -11.4% | -13.5% | -31.0% | |
| Q3 2021 | -11.4% | -13.5% | -31.0% | |
| Q2 2021 | +8.1% | -0.8% | +44.5% | |
| Q2 2020 | +8.1% | -0.8% | +44.5% | |
| Q1 2020 | -11.4% | -8.8% | +4.1% | |
| Q1 2021 | -16.1% | -22.2% | -17.9% | |
| Q4 2020 | +7.6% | +29.9% | +31.1% | |
| Q4 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro